Psychedelics Archives - Page 63 of 68

3 minute read

DMT Producer PsyBio And Shrooms Grower Red Light Holland Share Their Most Recent Financial Results

August 29, 4:09 PM

PsyBio Therapeutics (TSXV: PSYB) (OTCQB: PSYBF), a biotech developing medicines based on naturally-occurring psychedelic substances, and mushroom producer Red Light Holland Corp. (OTC Pink: TRUFF) announced the

PSYBF

1 minute read

New Meme MindMed Executes 1:15 Reverse Stock Split

By Lara Goldstein

August 29, 3:08 PM

As of today, psychedelics biotech Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) will trade its common shares based on a 1-for-15 reverse shar

MNMD

2 minute read

MindMed’s First Patient Dosing Clinical Trial With LSD For Treatment Of Generalized Anxiety Disorder

By Lara Goldstein

August 25, 1:42 PM

The clinical-stage biopharma company Mind Medicine -also known as MindMed (NASDAQ: MNMD), which recently made headlines reg

MNMD

8 minute read

Is Ibogaine A Safe And Effective Treatment For Addictions?

By El Planteo

August 25, 12:40 PM

By Santiago Federico Richetti via El Planteo.

NUMIF

3 minute read

Jamaica, Ecotourism & Psilocybin Microdosing: Silo Wellness Offers Psychedelic Holidays

By Lara Goldstein

August 24, 4:30 PM

Toronto-based psychedelics company Silo Wellness Inc. (OTCQB: SILFF) has launched its first ecotourism microdosing psilocybin resort and retreat center at Go Natural Jamaica in Long Bay, Portland, Jamaica.

SILFF

2 minute read

Study Reveals BetterLife’s LSD Analogue Boosts Structural Neuroplasticity Without Hallucinogenic Side Effects

By Lara Goldstein

August 24, 3:18 PM

A recent paper has provided new evidence that LSD has outstanding nootropic effects, believed to originate in the drug’s neuroplasticity promotion, in both animals and humans.

BETRF

2 minute read

Psychedelic-Based Cocaine Addiction Treatment Study Showing Positive Results. This Is What We Know

By Lara Goldstein

August 24, 3:15 PM

Israeli-Canadian biotech psychedelics developer Clearmind Medicine Inc. (OTC Pink: CMNDF) together with clinical-stage cannabinoid pharma company SciSparc Ltd.

CMNDF

2 minute read

Algernon Pharmaceuticals Closes Private Placement Round, Announces New Shareholder Distribution

By Lara Goldstein

August 23, 5:13 PM

Biotech clinical-stage company Algernon Pharmaceuticals Inc.

AGNPF

2 minute read

GH Research Shares Q2 2022 Financial Results & Business Updates

By Lara Goldstein

August 23, 4:10 PM

GH Research PLC (NASDAQ: GHRS), the clinical-stage biopharma company dedicated to transforming the treatment of psychiatric and neurological disorders through 5-MeO-DMT production, provided a financial and business update for the quarter ended June 30, 2022.

GHRS

2 minute read

Freedom Biosciences Gets $10.5M In Seed Financing For Psychedelics Research, This Is What We Know

By Lara Goldstein

August 23, 7:30 AM

Freedom Biosciences achieved a major $10.5 million in a seed financing round in which MBX Capital, PsyMed Ventures, Village Global and The Yale Startup, among others, participated.

BHVN